1. 64Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133+ cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite
   Yukie Yoshii et al, 2016, Cancer Letters CrossRef
2. Prognostic implications of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/CT in patients with glioma
   Akira Toriihara et al, 2018, Annals of Nuclear Medicine CrossRef
3. Positron emission tomography imaging in primary brain tumors
   Agostino Chiaravalloti et al, 2022, Nuclear Medicine and Molecular Imaging CrossRef
4. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research
   Alina Doctor et al, 2020, Cancers CrossRef
5. Imaging of hypoxia in mouse atherosclerotic plaques with 64Cu-ATSM
   Xingyu Nie et al, 2016, Nuclear Medicine and Biology CrossRef
6. Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model
   Zhao-Hui Jin et al, 2018, EJNMMI Research CrossRef
7. Integration of organoids in peptide drug discovery: Rise of the high‐throughput screening
   Siqi Zhang et al, 2023, VIEW CrossRef